On Sept. 17, 2026, Bayer announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to…
On Jun. 26, 2026, Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Researchers report developing…
On May 27, 2026, Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing…
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
On Apr. 29, 2026, Dr. Reddy’s Laboratories announced that it has received a Notice of Compliance (NOC) from…
On Apr. 14, 2026, Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI…
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
On Feb. 5, 2026, the University of North Dakota (UND) announced it is leading a major national effort…
On Jan. 23. 2026, a research team at Kumamoto University, led by Associate Professor Shingo Ito, announced they…
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
On Dec. 3, 2025, Massachusetts Institute of Technology (MIT) engineers announced they can accurately measure blood glucose by…
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
On Sept. 25, 2025, Biolinq, a pioneering developer of precision multi-analyte biosensors to improve metabolic health, announced the…
On Sept. 17, 2025, The New England Journal of Medicine published the results from the OASIS 4 phase…
On Sept. 8, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
On Sept. 5, 2025, in a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into…
On Aug. 20, 2025, the National Institute for Health and Care Excellence (NICE) announced that millions of people…
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
On Jul. 9, 2025, MIT engineers announced they have designed an implantable reservoir that can remain under the…
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…